KDM2A/7A-IN-1 |
Catalog No.GC36388 |
KDM2A/7A-IN-1은 히스톤 라이신 데메틸라제 KDM2A/7A의 동급 최초의 선택적 세포 투과성 억제제이며, KDM2A에 대한 IC50이 0.16μM이고 다른 JmjC 라이신 데메틸라제에 비해 75배의 선택성을 나타냅니다. 메틸 트랜스퍼라제 및 히스톤 아세틸 트랜스퍼라제에 대해 비활성.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2169272-46-0
Sample solution is provided at 25 µL, 10mM.
KDM2A/7A-IN-1 is a first-in-class, selective and cell-permeable inhibitor of histone lysine demethylases KDM2A/7A, with an IC50 of 0.16 μM for KDM2A, exhibits 75 fold selevtivity over other JmjC lysine demethylases, and is inactive on methyl transferases, and histone acetyl transferases[1]. IC50: 0.16 μM (KDM2A)[1]
KDM2A/7A-IN-1 ((S,S)-6) is a first-in-class, selective and cell-permeable inhibitor of histone lysine demethylases KDM2A/7A, with an IC50 of 0.16 μM for KDM2A, exhibits 75 fold selevtivity over other JmjC lysine demethylases, and is inactive to methyl transferases, and histone acetyl transferases[1].KDM2A/7A-IN-1 (0.4, 3.1, 6.2 μM) augments cellular H3K36me2 levels in HeLa cells ectopically expressing catalytically active KDM2A[1].
[1]. Gerken PA, et al. Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7. Angew Chem Int Ed Engl. 2017 Dec 4;56(49):15555-15559.
Average Rating: 5
(Based on Reviews and 29 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *